Show simple item record

dc.contributor.authorKenny, Roseen
dc.contributor.authorO'Halloran, Aislingen
dc.contributor.authorPidgeon, Grahamen
dc.contributor.authorFeeney, Joanneen
dc.date.accessioned2015-06-09T13:58:37Z
dc.date.available2015-06-09T13:58:37Z
dc.date.issued2015en
dc.date.submitted2015en
dc.identifier.citationOwusu Akuffo K, Nolan J, Stack J,Moran R, Feeney J,Kenny RA, Peto T, Dooley C, O?Halloran AM, Cronin C, and Beatty S., Prevalence of age-related macular degeneration in the Republic of Ireland., British Journal of Ophthalmology, 99, 2015, 1037-1044en
dc.identifier.otherYen
dc.identifier.urihttp://hdl.handle.net/2262/74026
dc.descriptionPUBLISHEDen
dc.description.abstractBackground Age-related macular degeneration (AMD) remains the most common cause of visual loss among subjects over 50 years of age in the developed world. The Irish Longitudinal study on Ageing (TILDA) is a population-based study of subjects aged 50 years or older, designed to investigate factors that influence ageing, and has enabled this investigation of the prevalence of AMD in the Republic of Ireland (ROI). Methods Data collected from a nationally representative sample of community-living older adults aged 50 years and over in ROI over the period November 2009 to July 2011. 5035 participants attended the TILDA health centre for assessment. Retinal photographs were obtained in 4859 of these participants. Retinal grading was performed in a masked fashion using a modified version of the International Classification and Grading System for AMD. Results Adjusting for lower response rates among older subjects, the estimated overall prevalence of any AMD was 7.2% (95% CI 6.5% to 7.9%) in the population aged 50 years or older. The estimated prevalence of early AMD was 6.6% (95% CI 5.9% to 7.3%), and the estimated prevalence of late AMD was 0.6% (95% CI 0.4% to 0.8%). Statistically significant associations with AMD included increasing age and family history of the condition. Conclusions This is the first study to provide prevalence estimates of AMD in ROI and will inform eye care professionals and policymakers involved in the delivery and planning of care for those afflicted with this condition.en
dc.format.extent1037-1044en
dc.language.isoenen
dc.relation.ispartofseriesBritish Journal of Ophthalmologyen
dc.relation.ispartofseries99en
dc.rightsYen
dc.subjectEpidemiology; Imaging; Macula; Public health; Visionen
dc.subject.lcshEpidemiology; Imaging; Macula; Public health; Visionen
dc.titlePrevalence of age-related macular degeneration in the Republic of Ireland.en
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/aiohalloen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/rkennyen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/pidgeongen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/feeneyjoen
dc.identifier.rssinternalid100072en
dc.identifier.doihttp://dx.doi.org/10.1136/bjophthalmol-2014-305768en
dc.rights.ecaccessrightsopenAccess
dc.subject.TCDThemeAgeingen
dc.subject.TCDTagAge related diseasesen
dc.subject.TCDTagEpidemiologyen
dc.subject.TCDTagPublic healthen
dc.subject.TCDTagVisionen
dc.identifier.orcid_id0000-0001-5498-4453en


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record